Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01138995 · ClinicalTrials.gov registry record · NA

Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop

A NA study, sponsored by Bioness.

Completed
Registry status
NA
Development phase
197
Enrollment target

NCT01138995: Completed NA study, sponsored by Bioness.

NCT01138995 is a NA study that has completed, run by Bioness. The registered enrollment target is 197 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01138995, a NA study, has completed, sponsored by Bioness.

COMPLETED
Registry status
NA
Development phase
197 participants
Enrollment target

Study Summary

The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.

Primary Outcome

Determine gait velocity during a 10 meter walk test for subjects using the L300 versus subjects using a standard "usual" ankle-foot orthosis (AFO). Long term device effect at comfortable gait speed in m/s. Walk test results at 30 weeks will be compared to baseline speed. The mean difference (improvement) between baseline and week 30 will be presented by study arm.

Interventions

  • DEVICE Ness L300
  • DEVICE Ankle-foot orthosis

Trial Details

FieldValue
Enrollment Target 197 participants
Start Date 2010-05
Est. Completion 2013-02
Phase NA
Bioness

6 total trials

What the finished NCT01138995 record still lists

NCT01138995 is an interventional study that assigns participants to a tested intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Ness L300 is the first listed.

NCT01138995 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01138995 about?

NCT01138995 is a clinical study titled "Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop". The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.

What is the current status of trial NCT01138995?

This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2010-05. Estimated completion is 2013-02.

What interventions are being tested in trial NCT01138995?

The interventions under investigation include: Ness L300 (DEVICE), Ankle-foot orthosis (DEVICE).

Who is sponsoring clinical trial NCT01138995?

This trial is sponsored by Bioness, which has 6 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01138995's enrollment target sits among peer trials

197 567th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04219254 · 197 participants · Phase 1

    A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

  • NCT06173778 · 197 participants · Phase 2

    Semaglutide for Post-Smoking Cessation Weight Management

  • NCT05203328 · 198 participants · NA

    Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy

  • NCT05426967 · 198 participants · NA

    rTMS for Military TBI-related Depression

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01138995, the US trial registry maintained by the National Library of Medicine. NCT01138995 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.